| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-05 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |